Prescribers letter

Veradigm ePrescribe is an electronic prescribing solution that provides a comprehensive and user-friendly experience for both physicians and patients. It offers various features to ensure that prescribers and patients are covered throughout the prescribing process.With Veradigm ePrescribe, physicians can choose between low-cost e-prescribing that saves time and eliminates the need for paper prescriptions, or advanced e-prescribing that keeps them up to date with regulatory mandates. This versatility allows physicians to customize their experience to suit their needs and preferences.With over 140,000 prescribers using Veradigm ePrescribe for hundreds of millions of transactions annually, it is a trusted and proven choice for electronic prescribing. Additionally, Veradigm ePrescribe’s mobile compatibility provides physicians with the flexibility to prescribe from anywhere they have internet access.Veradigm ePrescribe offers several benefits, including improved medication adherence, satisfaction, and efficiency. It allows physicians to prescribe electronically within their clinical workflow, saving time and streamlining the prescribing process. Overall, Veradigm ePrescribe is a reliable and efficient solution for electronic prescribing that can benefit both physicians and patients.

Your site. And most consumers know how crappy that is — e.g. they already bought the item and then they see tons of ads for the exact same item. Too many marketers are paying extra for hyper targeting — using many targeting parameters, thinking that it makes the ads more relevant for users. Research has shown that it doesn’t. (See: Despite Claims That More Targeting Means More Relevant Ads, Nope. Here’s Proof.) In fact, consumers are seeing far too many ads that are not relevant that they have taken action to protect themselves - by installing ad blockers. Over-Targeting and Campaign EffectivenessAdvertisers have gone too far down the rabbit hole of targeting in digital advertising. They have been misled by ad tech companies because the more targeting parameters they buy, the more revenue the ad tech companies make. Advertisers are over-targeting individuals and under-spending in basic brand building — exposing new potential customers to their brand and product. By doing so they are “leaving large sums of money on the table.” To illustrate with a more specific example — pharmaceutical companies have been desperately trying to target the 1% “high-prescribers” — doctors who already prescribe a lot of their particular drug. These advertisers are neglecting showing ads to the other 99% of doctors who are “low- to no-prescribers.” This much larger group may simply not be aware of the pharma company or their drug. If the pharma advertisers rebalanced their digital ad spending to include more brand-building and less over-targeting, they could drive a lot more sales. Small increases from a group that is 99X larger than the “high-prescribers” group far outweighs eking out a few more prescriptions from doctors who already prescribe a lot. Furthermore, most marketers don't need to know which specific individual bought something from them; they just need to know that more people bought something as a result of being exposed to the ads. This means that 3P cookies, which represent the individual are not necessary in the determination of whether campaigns worked. As long as advertisers can see “exposed” versus “not-exposed” and that exposed users

Cannabis strains are specific types of cannabis plants with certain properties or effects. They are used in a variety of different medical cannabis products to help treat patients with a variety of health conditions. The most common strains available in Australia are Sativa, Indica, or a hybrid of these two strains. Understanding how each strain affects different products is crucial to tailoring a treatment plan for patients. Little Green Pharma (LGP) is an industry-leading medical cannabis manufacturer in Australia. We offer valuable information and resources for prescribers, and pharmacists, who want to learn about the diverse legal medicinal cannabis landscape.What cannabis strains are used for medical cannabis?There are a variety of cannabis strains used for medical cannabis products. Different strains exhibit different tetrahydrocannabinol (THC) to cannabidiol (CBD) ratios that may assist registered medical practitioners when prescribing medicinal cannabis products to address the specific needs of their patients. The different types of strains found in medical cannabis are cultivated to produce specific effects which may benefit patients with a range of medical conditions. Their distinctive qualities allow registered medical practitioners to create personalised treatment plans for patients, along with other medications, to alleviate certain health conditions. When choosing a medicinal cannabis flower strain, there are a few elements that need to be considered by prescribers. Firstly, there is the percentage of THC and CBD in the product. This is important because for many, THC can cause psychoactive effects and is not a suitable treatment option. Someone with THC in their system may not legally drive or operate heavy machinery in most parts of Australia. This does not suit the lifestyle of certain patients. Another important consideration is the terpene profile of the product. Terpenes, especially in combination with one another, can augment the effects of cannabinoids (e.g. THC & CBD). This

Us—we just unplugged from Allscripts to ensure no transfer of data. Our systems remained operational.”In messages to its 2,300 members via social media, the New York American College of Emergency Physicians noted that it received an update from the state’s Department of Health that “a cyber incident regarding AllScripts has occurred” affecting “the ability for hospitals, clinics, nursing homes, individual prescribers and pharmacies to transmit and receive prescription electronically.” Prescribers in the states using Allscripts services for placing drug orders were allowed to use “paper official prescriptions” until services are restored, the group reported. In a published statement, Allscripts acknowledged the attack has affected clients’ services, but offered few specifics.“We are investigating a ransomware incident that has impacted a limited number of our applications,” the Allscripts statement noted. “We are working diligently to restore these systems, and most importantly, to ensure our clients’ data is protected.”Further, Allscripts believes that no data had been accessed or deleted in the ransomware attack.“Although our investigation is ongoing, there is currently no evidence that any data has been removed from our systems,” the company noted. “We regret any inconvenience caused by this temporary outage.”Conference calls over the weekend by the company indicated that service outages were continuing, and that the outage was expected to continue into Monday.Posts from providers on Twitter on Sunday noted that they were not able to access patient information from Allscripts.Yvette Crabtree, MD, an internal medicine physician with Sunflower Medical Group in Mission, Kan., reported in a Twitter post Friday that “the attack on Allscripts has taken down our e-prescribing, EPCS and some other services.”Industry reports of outages notwithstanding, Allscripts clients should be aware the company is being more upfront about the attack than many other vendors are, says Allen Briskin, a senior counsel at the Pillsbury, Winthrop Shaw Pittman